自動輸血装置の世界市場レポート 2025年

自動輸血装置市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0％で16億7,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、外来手術センターの拡大、産科における血液保存の重視、新興国ヘルスケア市場での採用に起因しています。予測期間の主な動向には、血液処理における技術的進歩、高度なセンサーの統合、さまざまな手技に対応したカスタマイズ、単一ドナーのクローズドループシステム、装置の小型化などがあります。

予測される心血管疾患（CVDs）の増加は、自己輸血装置市場の成長を促進します。CVDには心臓や血管の障害が含まれ、同種輸血への依存度を下げる上で重要な役割を果たします。これらの装置は、患者自身の血液の再注入を容易にし、ドナー輸血に関連するリスクを軽減します。特に、米国心臓協会の「心臓病と脳卒中の統計-2022年最新版」報告書では、CVDが世界最大の死亡原因であり、年間約1,790万人の命を奪っていることが強調されており、市場の軌跡を浮き彫りにしています。

血液保存に対する需要の高まりは、自動輸血装置市場の重要な促進要因になると予想されます。外科手術において、血液保存は手術中および手術後の同種輸血を回避し、患者の転帰を向上させ、患者の健康を守ることを目的としています。自動輸血装置は外科手術中の出血を効果的に最小化し、患者の回復向上に貢献します。世界保健機関（WHO）が2023年6月に発表した報告書によると、報告国の73％（171カ国中125カ国）が国家血液政策を実施しています。このことは、血液保存に向けた取り組みが広がっていることを示しており、市場の成長を裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界自動輸血装置 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の自動輸血装置市場：成長率分析
• 世界の自動輸血装置市場の実績：規模と成長, 2019-2024
• 世界の自動輸血装置市場の予測：規模と成長, 2024-2029, 2034F
• 世界自動輸血装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の自動輸血装置市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己輸血システム
• 消耗品および付属品
• 世界の自動輸血装置市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓血管手術
• 整形外科手術
• 神経外科
• 産婦人科手術
• その他の用途
• 世界の自動輸血装置市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 専門クリニック
• その他のエンドユーザー
• 世界の自動輸血装置市場、自己輸血システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科用自己血輸血システム
• 緊急自己輸血システム
• 連続フロー自己輸血システム
• 世界の自動輸血装置市場消耗品および付属品の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 収集貯水池
• 血液フィルター
• チューブセット
• パンプス
• 抗凝固剤

第7章 地域別・国別分析

• 世界の自動輸血装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の自動輸血装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 自動輸血装置市場：競合情勢
• 自動輸血装置市場：企業プロファイル
  • Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • LivaNova plc Overview, Products and Services, Strategy and Financial Analysis
  • Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Terumo Corporation
• Asahi Kasei Medical Co. Ltd.
• B. Braun Melsungen AG
• GE HealthCare Technologies Inc.
• Cerus Corporation
• Stryker Corporation
• Atrium Medical Technologies
• Brightwake Ltd.
• Getinge AB
• Beijing ZKSK Technology Co. Ltd.
• Braile Biomedica
• Redax S.p.A.
• Teleflex Incorporated
• Zimmer Biomet Holdings Inc.
• Gen World Medical Devices Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 自動輸血装置市場2029：新たな機会を提供する国
• 自動輸血装置市場2029：新たな機会を提供するセグメント
• 自動輸血装置市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Autotransfusion devices are tools utilized to collect and reintroduce a patient's own blood during medical procedures, reducing reliance on donated blood-a method known as autologous blood transfusion. This approach notably diminishes the necessity for allogeneic (from a separate donor) blood transfusions. These devices find widespread application in trauma care within emergency departments and surgical settings.

The primary components of autotransfusion devices encompass autotransfusion systems, consumables, and accompanying accessories. Autotransfusion systems encompass both medical devices and methodologies enabling patients to receive their own blood for transfusions, negating the need for external donor blood. They serve diverse medical applications such as cardiovascular, orthopedic, neurological, obstetrics, gynecology surgeries, among others, and cater to various end-users including hospitals, specialized clinics, and other medical facilities.

The autotransfusion devices market research report is one of a series of new reports from The Business Research Company that provides autotransfusion devices optical components market statistics, including autotransfusion devices optical components industry global market size, regional shares, competitors with a autotransfusion devices optical components market share, detailed autotransfusion devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the autotransfusion devices optical components industry. This autotransfusion devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autotransfusion devices market size has grown strongly in recent years. It will grow from$1.21 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to an increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, and efforts to reduce blood transfusion costs

The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, and adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, and miniaturization of devices.

The anticipated rise in cardiovascular diseases (CVDs) is set to propel growth within the autotransfusion device market. CVDs encompass a spectrum of heart and blood vessel disorders, and autotransfusion devices play a crucial role in reducing reliance on allogeneic blood transfusions. These devices facilitate reinfusion of a patient's own blood, mitigating the risks associated with donor blood transfusions. Notably, the American Heart Association's Heart Disease and Stroke Statistics-2022 Update report highlighted CVDs as the foremost global cause of mortality, claiming approximately 17.9 million lives annually, underscoring the market's trajectory.

The escalating demand for blood conservation is expected to be a significant driver for the autotransfusion devices market. Within surgical contexts, blood conservation aims to avoid allogeneic blood transfusions during and post-surgery to enhance patient outcomes and safeguard their well-being. Autotransfusion devices effectively minimize blood loss during surgical procedures, contributing to improved patient recovery. As per the June 2023 report by the World Health Organization, a substantial percentage of reporting countries, accounting for 73% or 125 out of 171, have implemented national blood policies. This indicates a widespread initiative toward blood conservation, affirming the market's growth.

The rising number of orthopedic surgeries is anticipated to fuel the growth of the autotransfusion devices market. Orthopedic surgeries involve medical procedures that address issues related to the musculoskeletal system, which includes bones, joints, ligaments, tendons, and muscles. The increase in these surgeries can be linked to a growing demand for treatments for injuries and degenerative conditions, as well as an aging population that requires joint replacements and repairs. Autotransfusion devices play a crucial role in orthopedic surgeries by collecting, processing, and reinfusing a patient's blood lost during the operation, thereby reducing the need for donor blood and minimizing the risk of transfusion-related complications. For example, the British Orthopaedic Association reported that in May 2022, England experienced over 42,000 orthopedic surgeries in March 2022, marking the highest number since June 2021. Consequently, the rising frequency of orthopedic surgeries is driving demand for autotransfusion devices.

Leading companies in the autotransfusion devices market are concentrating on creating technologically advanced solutions, including next-generation intelligent control software designed to improve precision, efficiency, and patient outcomes during blood transfusions. This next-generation software utilizes sophisticated algorithms to optimize the recovery, processing, and reinfusion of blood in real time, thereby enhancing both efficiency and patient safety. For example, in March 2023, Haemonetics Corporation, a U.S.-based provider of blood and plasma supplies and services, announced that the Cell Saver Elite+ Autotransfusion System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation software maximizes the recovery of red blood cells during surgical procedures where medium to high blood loss is anticipated. This innovative upgrade streamlines autotransfusion processes, minimizes unnecessary allogeneic transfusions, and ultimately leads to improved patient outcomes.

Innovations in product development, particularly the integration of next-generation intelligent control software, signify a pivotal focus among major autotransfusion device companies. This software upgrade, known as Intelligent Control, introduces significant enhancements aimed at simplifying operations, thereby enhancing efficiency and user experience. For instance, Haemonetics, a US-based healthcare company, received FDA 510(k) clearance for its next-generation Intelligent Control software in March 2023, specifically designed for the Cell Saver Elite+ autotransfusion system. This advancement in software technology reaffirms Haemonetics' commitment to pioneering solutions for improved patient outcomes in surgeries involving medium to high blood loss scenarios, spanning cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries.

Major companies operating in the autotransfusion devices market include Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomedica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The autotransfusion devices market consists of sales of on-pump transfusion devices and off-pump transfusion devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autotransfusion Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autotransfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autotransfusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autotransfusion devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Autotransfusion Systems; Consumables And Accessories
• 2) By Application: Cardiovascular Surgeries; Orthopedic Surgeries; Neurological Surgeries; Obstetrics And Gynecology Surgeries; Other Applications
• 3) By End-Use: Hospitals; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Autotransfusion Systems: Surgical Autotransfusion Systems; Emergency Autotransfusion Systems; Continuous Flow Autotransfusion Systems
• 2) By Consumables And Accessories: Collection Reservoirs; Blood Filters; Tubing Sets; Pumps; Anticoagulants
• Companies Mentioned: Becton Dickinson And Company; Medtronic plc; LivaNova plc; Haemonetics Corporation; Fresenius SE & Co KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autotransfusion Devices Market Characteristics

3. Autotransfusion Devices Market Trends And Strategies

4. Autotransfusion Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Autotransfusion Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Autotransfusion Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Autotransfusion Devices Market Growth Rate Analysis
• 5.4. Global Autotransfusion Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Autotransfusion Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Autotransfusion Devices Total Addressable Market (TAM)

6. Autotransfusion Devices Market Segmentation

• 6.1. Global Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autotransfusion Systems
• Consumables And Accessories
• 6.2. Global Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Obstetrics And Gynecology Surgeries
• Other Applications
• 6.3. Global Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specialty Clinics
• Other End Users
• 6.4. Global Autotransfusion Devices Market, Sub-Segmentation Of Autotransfusion Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Autotransfusion Systems
• Emergency Autotransfusion Systems
• Continuous Flow Autotransfusion Systems
• 6.5. Global Autotransfusion Devices Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collection Reservoirs
• Blood Filters
• Tubing Sets
• Pumps
• Anticoagulants

7. Autotransfusion Devices Market Regional And Country Analysis

• 7.1. Global Autotransfusion Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Autotransfusion Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autotransfusion Devices Market

• 8.1. Asia-Pacific Autotransfusion Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autotransfusion Devices Market

• 9.1. China Autotransfusion Devices Market Overview
• 9.2. China Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autotransfusion Devices Market

• 10.1. India Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autotransfusion Devices Market

• 11.1. Japan Autotransfusion Devices Market Overview
• 11.2. Japan Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autotransfusion Devices Market

• 12.1. Australia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autotransfusion Devices Market

• 13.1. Indonesia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autotransfusion Devices Market

• 14.1. South Korea Autotransfusion Devices Market Overview
• 14.2. South Korea Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autotransfusion Devices Market

• 15.1. Western Europe Autotransfusion Devices Market Overview
• 15.2. Western Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autotransfusion Devices Market

• 16.1. UK Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autotransfusion Devices Market

• 17.1. Germany Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autotransfusion Devices Market

• 18.1. France Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autotransfusion Devices Market

• 19.1. Italy Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autotransfusion Devices Market

• 20.1. Spain Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autotransfusion Devices Market

• 21.1. Eastern Europe Autotransfusion Devices Market Overview
• 21.2. Eastern Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autotransfusion Devices Market

• 22.1. Russia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autotransfusion Devices Market

• 23.1. North America Autotransfusion Devices Market Overview
• 23.2. North America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autotransfusion Devices Market

• 24.1. USA Autotransfusion Devices Market Overview
• 24.2. USA Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autotransfusion Devices Market

• 25.1. Canada Autotransfusion Devices Market Overview
• 25.2. Canada Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autotransfusion Devices Market

• 26.1. South America Autotransfusion Devices Market Overview
• 26.2. South America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autotransfusion Devices Market

• 27.1. Brazil Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autotransfusion Devices Market

• 28.1. Middle East Autotransfusion Devices Market Overview
• 28.2. Middle East Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autotransfusion Devices Market

• 29.1. Africa Autotransfusion Devices Market Overview
• 29.2. Africa Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autotransfusion Devices Market Competitive Landscape And Company Profiles

• 30.1. Autotransfusion Devices Market Competitive Landscape
• 30.2. Autotransfusion Devices Market Company Profiles
  • 30.2.1. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. LivaNova plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius SE & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Autotransfusion Devices Market Other Major And Innovative Companies

• 31.1. Terumo Corporation
• 31.2. Asahi Kasei Medical Co. Ltd.
• 31.3. B. Braun Melsungen AG
• 31.4. GE HealthCare Technologies Inc.
• 31.5. Cerus Corporation
• 31.6. Stryker Corporation
• 31.7. Atrium Medical Technologies
• 31.8. Brightwake Ltd.
• 31.9. Getinge AB
• 31.10. Beijing ZKSK Technology Co. Ltd.
• 31.11. Braile Biomedica
• 31.12. Redax S.p.A.
• 31.13. Teleflex Incorporated
• 31.14. Zimmer Biomet Holdings Inc.
• 31.15. Gen World Medical Devices Corporation

32. Global Autotransfusion Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autotransfusion Devices Market

34. Recent Developments In The Autotransfusion Devices Market

35. Autotransfusion Devices Market High Potential Countries, Segments and Strategies

• 35.1 Autotransfusion Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Autotransfusion Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Autotransfusion Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer